• Mashup Score: 0

    Russell J. Ledet, PhD, discusses being a Black man in the field of oncology.

    Tweet Tweets with this article
    • Medical institutions are “considering” the idea of evaluating their role in health disparities that have been exacerbated by the #COVID-19 pandemic but were here long before that. #raceincancer #raceinoncology https://t.co/92WkRo69qk

  • Mashup Score: 0

    Data from a subgroup analysis of the phase 2 GRIFFIN study demonstrated that adding daratumumab to lenalidomide, bortezomib, and dexamethasone improved depth of response, stringent complete response, and minimal residual disease negativity, in Black patients with newly diagnosed multiple myeloma.

    Tweet Tweets with this article
    • .@AjayNookaMD, of @WinshipAtEmory, on the objective of the phase 2 GRIFFIN. #mmsm #raceinoncology #raceincancer https://t.co/in8eUFEspj https://t.co/19VIKmpWmx

  • Mashup Score: 0

    Data from a subgroup analysis of the phase 2 GRIFFIN study demonstrated that adding daratumumab to lenalidomide, bortezomib, and dexamethasone improved depth of response, stringent complete response, and minimal residual disease negativity, in Black patients with newly diagnosed multiple myeloma.

    Tweet Tweets with this article
    • Quad Therapy Induces Deep Responses in Black Patients With Multiple Myeloma @AjayNookaMD @EmoryUniversity #mmsm #raceincancer #raceinoncology https://t.co/45KVGAFahY

  • Mashup Score: 0

    In our exclusive interview, Rodolfo Gutierrez, MD, discusses the issues that surround access to care and clinical outcomes with Hispanic patients, efforts The Angeles Clinic has spearheaded to bridge this gap in care, and the importance of patient and provider education and awareness.

    Tweet Tweets with this article
    • JUST RELEASED: In our latest episode of #OncLiveOnAir, Rodolfo Gutierrez, MD, of @angelesclinic, discusses oncologic issues that pertain to the Latino population. #raceinoncology #raceincancer Listen now: https://t.co/r7RQNd600C! https://t.co/naywZdlLRU